Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $109.65 | Total: $548.25 |
| 1 | 10 | $92.88 | Total: $928.80 |
| 1 | 25 | $78.69 | Total: $1,967.25 |
| 1 | 50 | $67.08 | Total: $3,354.00 |
| 1 | 100 | $58.05 | Total: $5,805.00 |
Overview
SB273005 is an orally active and potent nonpeptide integrin ?v?3 antagonist that inhibits ?v?3 and ?v?5 and reduces the production of Th2 cells and the cytokine IL-10 in pregnant mice.
Chemical Properties
| Molecular Formula | C22H24F3N3O4 |
| Molecular Weight | 451.44 |
| CAS Numbers | 205678-31-5 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(C(O)=O)[C@@H]1CC=2C(CN(CC(F)(F)F)C1=O)=CC(OCCC=3N=C(NC)C=CC3)=CC2 |
Storage and Handling
0C Short Term, -20C Long Term
References
Badger AM, et al. Disease-modifying activity of SB 273005, an orally active, nonpeptide alphavbeta3 [vitronectin receptor] antagonist, in rat adjuvant-induced arthritis. Arthritis Rheum. 2001 Jan;44[1] 128-37.